Effectiveness Varies by Individual Results with ColonBroom differ from person to person
In STEP-1 (N=1,961), 29.7% of participants randomized to semaglutide 2.4 mg reported diarrhea over 68 weeks, compared with 15.9% in the placebo group [4]
Current human data therefore cannot attribute fatigue, cold intolerance, or brain fog to altered T4-to-T3 conversion or validate a Free-T3-only monitoring rule. The obese trial cohorts lost roughly 8% of body weight at 1 mg in Phase 2 and about 28% at 12 mg in the 80-week Phase 3 trial
The statements made on this website have not been evaluated by the Food & Drug Administration
The compassionate team at Journey Hillside has extensive experience helping individuals safely transition from benzodiazepine dependence to sustainable anxiety management strategies
Contact your GP urgently if you soak through sanitary protection hourly for several hours, pass large clots repeatedly, experience bleeding between periods, or develop symptoms of anaemia such as fatigue, breathlessness, or dizziness